Amid the memory chip supercycle, our estimates show that low-end/mid-range/high-end phones will see a 16.7%/12.0%/9.3% increase in BOM cost in 2026, which will be absorbed by consumers, smartphone OEMs and component suppliers. The impact will spread unevenly across the industry, but high-end phones will be less affected than others; smartphone OEMs absorbing the bulk of the costs will make component suppliers better positioned, and Apple’s supply chain will outperform Android thanks to Apple’s s...
Xiaomi’s EV business has turned around in 3Q and shipment numbers are on track to reach consensus estimates of over 400,000 units. The tight memory supply and cost hikes will inevitably impact Xiaomi’s margins through 2026, although Xiaomi is able to secure sufficient supply for 2026 and is looking to partially mitigate cost pressure through ASP hikes and shifts to premium devices. Maintain BUY; cut target price to HK$54.60 but advise staying on the sidelines amid poor market sentiment.
Top Stories Initiate Coverage | Pony AI Inc (PONY US/BUY/US$12.18/Target: US$26.10) Pony AI is a global leader in autonomous mobility, leveraging its virtual driver technology to enable the mass production and deployment of autonomous vehicles across diverse regions. We expect revenue to grow at a three-year CAGR of 65% from 2024-27, net loss to narrow, and bottom line to turn around in 2028, driven by large-scale commercialisation. Initiate coverage with BUY and a target price of US$26.10 for ...
Greater China Initiate Coverage | Pony AI Inc (PONY US/BUY/US$12.18/Target: US$26.10) Pony AI is a global leader in autonomous mobility, leveraging its virtual driver technology to enable the mass production and deployment of autonomous vehicles across diverse regions. We expect revenue to grow at a three-year CAGR of 65% from 2024-27, net loss to narrow, and bottom line to turn around in 2028, driven by large-scale commercialisation. Initiate coverage with BUY and a target price of US$26.10...
Xiaomi’s EV business is expected to finally reach profitability at the operating level, thanks to rising operating scale and operational optimisation of its existing plant. Meanwhile, the smartphone business faces some near-term headwinds from rising memory prices, which have impacted margins and is likely to persist in the coming quarters. The IoT segment’s growth is slowing, but we believe it is still operating at a good scale, with margins still expanding sequentially. Maintain BUY; trim targ...
Greater China Company Results | China Resources Building Materials Technology (1313 HK/BUY/HK$1.75 /Target: HK$2.06) CR Building Mat Tech’s 9M25 results were below expectations, with earnings up 7.3% yoy to Rmb331m on lower coal costs. Weather disruptions weighed on 3Q25 cement sales volume, while Guangdong prices stayed soft. Aggregates turned loss-making, prompting capex cuts. Management guided 2025 sales of 55m tonnes (-10.9% yoy) and highlighted a planned capacity-exit fund as a medium-term ...
Top Stories Company Results | CMOC (3993 HK/BUY/HK$17.04/Target: HK$20.30) CMOC’s 9M25 net profit rose 72.6% yoy to Rmb14,279.7m, driven by higher copper prices and a record output of 543,000 tonnes (+14.1% yoy). Gross margin expanded to 22.0% (+4.3ppt yoy) on stronger copper and cobalt prices, while the DRC export quota continued to constrain cobalt sales. KFM Phase 2 will add around 100,000 tonnes to copper capacity by 2027. We maintain BUY on CMOC with a higher target price of HK$20.30. Com...
AI infrastructure investments continue to surge, with consensus forecasts for top China/US hyperscalers growing over 10% and 20% qoq respectively. This should fuel AI server demand growth of 60% yoy by 2026. Consumer electronics remain strong, with iPhone 17 lead times far exceeding that of iPhone 16 and Android flagships set for further spec upgrades, which will support multi-year shipment growth. China’s automation and robotics markets are also recovering faster than expected, with humanoid ro...
In August, the HSI and MSCI China Index hit their ytd highs, posting gains of 1.2% mom and 4.2% mom respectively, supported by dovish remarks from Fed Chair J. Powell at Jackson Hole. Looking ahead, we expect some consolidation as most of the positives have been priced in and are biased to SELL. We add Anta, BYDE and CSCEC to our BUY list, while initiating SELL calls on Li Auto and OOIL. We take profit on Innovent, JD Logistics, Lenovo, Sino Biopharm, Tencent and TME.
Xiaomi’s 2Q25 net profit was a solid beat at Rmb10.8b, thanks to strong IoT sales and robust EV margins, coupled with fair value changes on financial instruments. Looking ahead, the EV business is set for a stronger print due to the YU7 deliveries, while margins for the smartphone business remain under pressure due to elevated memory costs. Maintain BUY; maintain target price at HK$69.20.
KEY HIGHLIGHTS Results China Resources Beer (291 HK/BUY/HK$28.28/Target: HK$33.80) 1H25 results beat expectations. Sales volume of sub-premium beer and above saw mid-to-high single-digit growth. In the 15th Five-Year Plan, CR Beer will remain focused on Heineken as its core, while strengthening the sub-premium segment as another growth driver. The baijiu business is not expected to deteriorate further amid the adjustment phase in 2H25, but any potential impairment will still depend on business...
GREATER CHINA Results China Resources Beer (291 HK/BUY/HK$28.28/Target: HK$33.80): 1H25: Results beat; Heineken and sub-premium the core for next stage. Guangzhou Tinci Materials Technology (002709 CH/BUY/Rmb20.60/Target: Rmb30.00): 2Q25: Earnings miss on ASP and margins; Maintain BUY. Cut target price from Rmb39.60 to Rmb30.0. Xiaomi Corp (1810 HK/BUY/HK$52.40/Target: HK$69.20): 2Q25: Record-high bottom line; EV business to be boosted by YU7 deliveries. Maintain BUY. XPeng Inc (9868 HK/BUY/HK$7...
Xiaomi is set to report its 2Q25 earnings later this month. We expect robust revenue growth supported by the IoT, EV and internet services segments. However, margins are projected to fall sequentially, mainly due to rising DDR4 prices for the smartphone business and a shift in the IoT product mix. Overall, we expect adjusted net profit to grow 71.4% yoy to Rmb10.3b. Maintain BUY; trim target price slightly to HK$69.20.
KEY HIGHLIGHTS Results BeOne Medicines (6160 HK/BUY/HK$182.70/Target: HK$240.00) BeOne Medicines’ 1H25 revenue surged by 44.7% yoy to US$2.4b and adjusted net earnings amounted to US$389m, beating consensus estimates. Management raised revenue and gross margin guidance in 2025. We believe BRUKINSA's strong sales outlook and improving operational efficiency bode well for robust earnings and free cash flow expansion. Its R&D efforts will also support sustainable long-term growth through new prod...
In July, the HSI and MSCI China index extended their growths, rising 2.9% mom and 4.5% mom respectively to reach their peak on 24 July before pulling pack in the latest week, as investors tend to take profit after the Politburo announcement. With another 90-day tariff delay from the US, we maintain a positive outlook for leading domestic stocks in healthcare and IT. New additions to our BUY list are JBM Healthcare and Lenovo. We take profit on CATL, Han’s Laser, KE Holdings and Longfor.
June’s HSI and MSCI China Index rose 3.4% mom and 4.0% mom respectively, despite the pullback due to the Middle East tensions. July may see increased volatility as the US looks to bring the tariff negotiations to a close. At this juncture, we continue to favour domestic policy beneficiaries and sector leaders. New additions to our BUY list are CATL, KE Holdings, Longfor, Midea Group, Tencent and Tencent Music Entertainment. We take profit on Prudential.
GREATER CHINA Strategy Alpha Picks: July Conviction Calls Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. Sector Online Games Upcoming new game releases to capitalise on the summer holiday season. INDONESIA Strategy Alpha Picks: Good Performances In June Our new alpha picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA...
Xiaomi officially launched the YU7 SUV model, along with the AI Glasses and a range of other smartphones and IoT products. Specifications and pricing for YU7 are in line, but its initial orders in the first hour has surpassed 289,000 units which is well above our/market expectations, and this is usually a solid indicator of positive share price performance in the coming days. Maintain BUY and keep target price at HK$69.90.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.